Infantile Hemangioma Tumor Size and C/T Polymorphism Within CTCF Binding Site Six
N/A
1 Year
Both
Hemangioma
Trial Information
Infantile Hemangioma Tumor Size and C/T Polymorphism Within CTCF Binding Site Six
This study seeks to examine a potential relationship between CTCF genotype and hemangioma
size and growth rate. In addition to the initial visit, patients will return to our clinic
for evaluation at two weeks, one month, two months, six months, and one year. At each
visit, patients' hemangiomas will be measured and photographed. At one point over the
course of evaluation, a blood sample will be taken from each patient for evaluation of C/T
polymorphism at CTCF binding site six.
Inclusion Criteria:
- Hemangioma must appear within one month prior to enrollment
Exclusion Criteria:
- Hemangioma appeared before one month prior to enrollment
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Principal Investigator
Deepak Narayan, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Yale University
Authority:
United States: Institutional Review Board
Study ID:
0507000430
NCT ID:
NCT00974129
Start Date:
September 2009
Completion Date:
May 2011
Related Keywords:
- Hemangioma
- Hemangioma
- Hemangioma, Capillary
Name | Location |
|---|---|
| Yale Dermatology Associates | New HAven, Connecticut 06519 |
